India  

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Video Credit: ANI - Duration: 02:24s - Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites.

Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.


You Might Like


💡 newsR Knowledge: Other News Mentions

Balram Bhargava Indian science administrator

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine [Video]

Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India. He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance. He said, "3 vaccines are at clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."

Credit: ANI    Duration: 01:21Published
Second national sero-survey to be completed in September first week: ICMR [Video]

Second national sero-survey to be completed in September first week: ICMR

Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication. Bhargava said, "ICMR sero survey is publication in-progress. It should appear by this week in the Indian Journal of Medical Research. It has been peer reviewed. The second national sero-survey should be completed in the first week September". On situation of COVID-19 vaccines in India, Balram Bhargava said, "Three COVID-19 vaccines are ahead in the race in India. Serum Institute's vaccine is in phase 2(B) and phase 3 trials and Bharat Biotech and Zydus Cadila's vaccines have completed phase 1 trial."

Credit: ANI    Duration: 01:49Published
Irresponsible people without masks are driving pandemic in India: ICMR [Video]

Irresponsible people without masks are driving pandemic in India: ICMR

Indian Council of Medical Research, Director General Balram Bhargava when asked on who is diving the pandemic, said, "Irresponsible, less cautious people who are not wearing masks are driving the pandemic in India." He further reacted on re-infection of one case in Hong Kong. He said, "We have read report on re-infection of one case in Hong Kong. It can depend on several factors. It could be related to the patient's immune status, whether the virus has mutated. We need to closely follow it up, but at the same time we don't need to be alarmed".

Credit: ANI    Duration: 01:15Published

Oxford University Police Oxford University Police

For high-risk groups, government plans to fast-track vaccine

India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum..
IndiaTimes
Hancock on coronavirus vaccine trial pause [Video]

Hancock on coronavirus vaccine trial pause

Health Secretary Matt Hancock seeks to reassure the public as trials of the Oxford University Covid-19 vaccine have been put on hold owing to a reported side effect in a patient in the UK. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:37Published
FPL crowns new champion after controversy [Video]

FPL crowns new champion after controversy

The Fantasy Premier League has named a new winner for the 2019/20 season afterthe original was disqualified for a breach of the game’s terms and conditions.Josh Bull, a researcher in mathematical oncology at Oxford University, hasreplaced Bulgarian fantasy football manager Aleksandar Antonov two weeks afterthe end of the season.

Credit: PA - Press Association STUDIO    Duration: 01:22Published
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again [Video]

COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief Minister of Madhya Pradesh Shivraj Singh Chouhan on August 03 again tested positive for COVID-19 on the 10th day of his admission to hospital. Today, Andhra Pradesh reported 7,822 new COVID-19 cases, taking the total number of coronavirus cases in the state 1,66,586. Uttar Pradesh reported 4,473 new COVID-19 cases and 50 deaths in the last 24 hours, taking active cases to 40,191 and death toll to 1,778. Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths in the last 24 hours, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths.

Credit: ANI    Duration: 01:38Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the..
DNA
Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning [Video]

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning

From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:18Published

Serum Institute of India to resume clinical trials of AstraZeneca-Oxford's COVID-19 vaccine after DGCI nod

The Pune-based Serum Institute of India (SII) is all set to resume the clinical trials of AstraZeneca-Oxford's COVID-19 vaccine candidate AZD1222 after receiving..
DNA

Indian Council of Medical Research Indian Council of Medical Research organization

No significant mutation in COVID-causing SARS-CoV-2 virus: Health Minister

The Union Health Minister Harsh Vardhan on Sunday (September 20, 2020) stated that there has been no significant mutation in SARS-CoV-2 (a virus that causes..
DNA
Record 12 lakh COVID tests conducted across India in last 24 hours [Video]

Record 12 lakh COVID tests conducted across India in last 24 hours

In the last 24 hours, 12 lakh COVID tests were conducted across the country which is an all-time record high. India's total number of coronavirus tests is more than 6.37 crore so far. Meanwhile, India's COVID-19 case tally crossed 54-lakh mark with a spike of 92,605 new cases and 1,133 deaths in last 24 hours. According to Ministry of Health and Family Welfare, the total case tally stands at 54,00,620 including 10,10,824 active cases, 43,03,044 cured/discharged/migrated and 86,752 deaths. As per Indian Council of Medical Research (ICMR), 6,36,61,060 samples were tested up to 19th Sep, of these, 12,06,806 samples were tested yesterday.

Credit: ANI    Duration: 01:26Published
Watch: Satendar Jain reacts on community spread of COVID-19 on Delhi [Video]

Watch: Satendar Jain reacts on community spread of COVID-19 on Delhi

Health Minister of Delhi, Satyendar Jain on September 19 briefed media over the current situation of COVID-19 in national capital. He said, "When people in such large numbers are getting infected in Delhi and other parts of the country, it should've been admitted that there is community spread... but only ICMR or Central govt can comment on this."

Credit: ANI    Duration: 01:14Published

Pune Pune Place in Maharashtra, India

Two Pune artists are on a mission to clean and paint the city [Video]

Two Pune artists are on a mission to clean and paint the city

Sneha Chakraborty and Kartik Sharma hope to paint more than 100 public walls in Pune, and eventually include AR features to each painting. Watch the video for more details.

Credit: HT Digital Content    Duration: 01:47Published
Maha Dy CM Pawar reviews ongoing construction work of Pune Metro [Video]

Maha Dy CM Pawar reviews ongoing construction work of Pune Metro

Maharashtra Deputy Chief Minister Ajit Pawar reviewed ongoing construction work of Pune Metro on September 17. He is in Pune to attend weekly review meeting on COVID-19 that will be held later today. Deputy CM Pawar was accompanied by Maharashtra government officials.

Credit: ANI    Duration: 01:29Published
Covid patient dies at home in Pune, body carried on handcart for cremation [Video]

Covid patient dies at home in Pune, body carried on handcart for cremation

A Covid-19 patient died at home in Pune after being unable to get a bed in any hospital. The patient from Khanapur village of Pune died on September 11. "He died because he could not get a bed in any hospital. When his health deteriorated, we called the ambulance but to no avail," said Nilesh Javalkar, the village sarpanch. The youth’s body was carried on a handcart for cremation as no vehicles were available. Watch the full video.

Credit: HT Digital Content    Duration: 01:43Published

Drugs Controller General of India organization

COVID-19: DCGI approves CSIR's paper-based testing kit [Video]

COVID-19: DCGI approves CSIR's paper-based testing kit

Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR's paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, "Our Delhi CSIR lab's been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA. Mande further explained the functioning of the paper based test. "It's different as RTPCR detects RNA and amplifies it using a polymerase chain reaction that is costly. This paper-based test also detects RNA but by a CRISPR guided system. The paper lights up if there is any virus RNA to show a sample is positive, in 45 minutes," he added.

Credit: ANI    Duration: 02:43Published

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19..
IndiaTimes

Related news from verified sources

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage...
IndiaTimes - Published


Tweets about this

Dark17160

DarkWolf RT @DrSubhasree: Oxford COVID 19 vaccine trial is stopped over SAFETY concern: #AstraZeneca put a hold on the late stage trial of it's high… 3 minutes ago

Sublimemanx

🏴󠁧󠁢󠁳󠁣󠁴󠁿 Sublimemanx The Gamer (Sub) 🇬🇧 RT @jackfmnews: Late-stage studies of the jab at Oxford have been stopped while an investigation is carried out https://t.co/KKNYqVrboI 3 minutes ago

jackfmnews

JACK News Late-stage studies of the jab at Oxford have been stopped while an investigation is carried out https://t.co/KKNYqVrboI 7 minutes ago

drcritiquealot

A - D RT @AfricanAU: "AstraZeneca has "voluntarily paused" late-stage trials of the highly-anticipated COVID-19 vaccine it is developing with the… 10 minutes ago

AfricanAU

African Australian "AstraZeneca has "voluntarily paused" late-stage trials of the highly-anticipated COVID-19 vaccine it is developing… https://t.co/w9hz7Iz0ce 43 minutes ago

yuthikabhargava

Yuthika Bhargava RT @vijaythehindu: AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a susp… 59 minutes ago

YashKas11275858

Yash Kashyap RT @the_hindu: AstraZeneca has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine it is developing along with Un… 1 hour ago

Nksagar

Naresh Kumar Sagar UK Oxford vaccine put on hold over safety reasons. AstraZeneca PLC has put a hold on the late-stage trial of the hi… https://t.co/u4Vd1UiJJi 1 hour ago


Related videos from verified sources

If all goes well, expect COVID vaccine by early next year: AIIMS doctor [Video]

If all goes well, expect COVID vaccine by early next year: AIIMS doctor

As clinical trials of different COVID-19 vaccines are in various phases across the globe, an AIIMS (All India Institute of Medical Sciences) doctor said that if everything goes as planned, people can..

Credit: ANI     Duration: 02:26Published
India's COVID recoveries cross 41 lakh mark, active infections past 10 lakh [Video]

India's COVID recoveries cross 41 lakh mark, active infections past 10 lakh

As per the data released by Ministry of Health and Family Welfare, India on September 18 reported single-day spike of 96,424 new coronavirus cases in the last 24 hours. 1,174 deaths in the same period,..

Credit: ANI     Duration: 01:38Published
Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News [Video]

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's..

Credit: Oneindia     Duration: 01:03Published